The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.. The drug will be ...

when it's for prevention," said Johanna Mercier, Gilead's chief commercial officer ... The Supreme Court may hinder access to this HIV prevention, gay sex drug. Why? More than 1 million new HIV cases ...

Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. FDA approves powerful HIV drug with the potential to end the ...

The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the Centers for Disease Control and Prevention, or CDC.

HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to beat back the virus and prevent new infections.